Commercialisation of novel technologies
A key focus of the research undertaken at CPES is the development of novel technologies in the general area of pharmaceutical and healthcare formulation. The centre has an excellent record of developing intellectual property for commercialisation through collaboration with appropriate industry partners.
We are currently seeking commercial partners for the following innovative technologies:
- Non-hygroscopic effervescent solid dosage formulations
- Novel abuse resistant systems for opiate drug delivery
- Solvent free process for manufacture of co-crystals
- Stable novel polymorphs of pharmaceutical actives